Biblio

Export 2804 results:
Author Keyword Title Type [ Year(Asc)]
2021
A. Kapasi, Yu, L., Stewart, C., Schneider, J. A., Bennett, D. A., and Boyle, P. A., Association of Amyloid-β Pathology with Decision Making and Scam Susceptibility., J Alzheimers Dis, vol. 83, no. 2, pp. 879-887, 2021.
M. Babić Leko, Jurasović, J., Perković, M. Nikolac, Španić, E., Sekovanić, A., Orct, T., Škudar, V. Lukinović, Baronica, K. Bačić, Kiđemet-Piskač, S., Vogrinc, Ž., Pivac, N., Borovečki, F., Hof, P. R., and Šimić, G., The Association of Essential Metals with APOE Genotype in Alzheimer's Disease., J Alzheimers Dis, vol. 82, no. 2, pp. 661-672, 2021.
M. Germán Borda, Copete, A. María Aya, Tovar-Rios, D. Alejandro, Jaramillo-Jimenez, A., Giil, L. Melvær, Soennesyn, H., Gómez-Arteaga, C., Venegas-Sanabria, L. Carlos, Kristiansen, I., Chavarro-Carvajal, D. Andrés, Caicedo, S., Cano-Gutierrez, C. Alberto, Vik-Mo, A., and Aarsland, D., Association of Malnutrition with Functional and Cognitive Trajectories in People Living with Dementia: A Five-Year Follow-Up Study., J Alzheimers Dis, vol. 79, no. 4, pp. 1713-1722, 2021.
M. M. Gonzales, Samra, J., O'Donnell, A., R Mackin, S., Salinas, J., Jacob, M., Satizabal, C. L., Aparicio, H. J., Thibault, E. G., Sanchez, J. S., Finney, R., Rubinstein, Z. B., Mayblyum, D. V., Killiany, R. J., Decarli, C. S., Johnson, K. A., Beiser, A. S., and Seshadri, S., Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study., J Alzheimers Dis, vol. 82, no. 1, pp. 249-260, 2021.
K. Hirao, Yamashita, F., Tsugawa, A., Haime, R., Fukasawa, R., Sato, T., Kanetaka, H., Umahara, T., Sakurai, H., Hanyu, H., and Shimizu, S., Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment., J Alzheimers Dis, vol. 80, no. 2, pp. 877-883, 2021.
C. Themistocleous, Ficek, B., Webster, K., Ouden, D. - Bden, Hillis, A. E., and Tsapkini, K., Automatic Subtyping of Individuals with Primary Progressive Aphasia., J Alzheimers Dis, vol. 79, no. 3, pp. 1185-1194, 2021.
H. Jakubowski, Zioła-Frankowska, A., Frankowski, M., Perła-Kaján, J., Refsum, H., de Jager, C. A., and A Smith, D., B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment., J Alzheimers Dis, vol. 84, no. 3, pp. 1039-1055, 2021.
A. D. Dekker, Ulgiati, A. M., Groen, H., Boxelaar, V. A., Sacco, S., Falquero, S., Carfi, A., di Paola, A., Benejam, B., Valldeneu, S., Fopma, R., Oosterik, M., Hermelink, M., Beugelsdijk, G., Schippers, M., Henstra, H., Scholten-Kuiper, M., Willink-Vos, J., de Ruiter, L., Willems, L., de Jong, A. Loonstra-, Coppus, A. M. W., Tollenaere, M., Fortea, J., Onder, G., Rebillat, A. - S., Van Dam, D., and De Deyn, P. P., The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation., J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
A. Mulak, Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease., J Alzheimers Dis, vol. 84, no. 2, pp. 461-477, 2021.
W. Hendricus Quint, Matečko-Burmann, I., Schilcher, I., Löffler, T., Schöll, M., Burmann, B. Marcus, and Vogels, T., Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein., J Alzheimers Dis, vol. 80, no. 2, pp. 813-829, 2021.
I. Koychev, Jansen, K., Dette, A., Shi, L., and Holling, H., Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis., J Alzheimers Dis, vol. 79, no. 1, pp. 177-195, 2021.
L. Smith, Shin, J. Il, Oh, H., Carmichael, C., Jacob, L., Stefanac, S., Lindsay, R. K., Soysal, P., Veronese, N., Tully, M. A., Butler, L., Barnett, Y., and Koyanagi, A., Body Mass Index and Mild Cognitive Impairment Among Middle-Aged and Older Adults from Low- and Middle-Income Countries., J Alzheimers Dis, vol. 85, no. 3, pp. 1095-1105, 2021.
A. G. Senejani, Maghsoudlou, J., El-Zohiry, D., Gaur, G., Wawrzeniak, K., Caravaglia, C., Khatri, V. A., MacDonald, A., and Sapi, E., Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer's Disease Brain Tissues., J Alzheimers Dis, vol. 85, no. 2, pp. 889-903, 2021.
I. A. Clark and Vissel, B., Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches., J Alzheimers Dis, vol. 79, no. 3, pp. 931-948, 2021.
H. Khodadadi, Salles, É. Lopes, Jarrahi, A., Costigliola, V., Khan, M. B., Yu, J. C., Morgan, J. C., Hess, D. C., Vaibhav, K., Dhandapani, K. M., and Baban, B., Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease., J Alzheimers Dis, vol. 80, no. 3, pp. 973-977, 2021.
A. M. Stickel, Tarraf, W., Gonzalez, K. A., Isasi, C. R., Kaplan, R., Gallo, L. C., Zeng, D., Cai, J., Pirzada, A., Daviglus, M. L., Goodman, Z. T., Schneiderman, N., and González, H. M., Central Obesity, Cardiometabolic Risk, and Cognitive Change in the Study of Latinos: Investigation of Neurocognitive Aging., J Alzheimers Dis, vol. 82, no. 3, pp. 1203-1218, 2021.
K. Kawamura, Miyajima, M., Nakajima, M., Kanai, M., Motoi, Y., Nojiri, S., Akiba, C., Ogino, I., Xu, H., Kamohara, C., Yamada, S., Karagiozov, K., Ikeuchi, T., Kondo, A., and Arai, H., Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus., J Alzheimers Dis, vol. 83, no. 1, pp. 179-190, 2021.
K. W. VanDusen, Li, Y. - J., Cai, V., Hall, A., Hiles, S., J Thompson, W., M Moseley, A., Cooter, M., Acker, L., Levy, J. H., Ghadimi, K., Quiñones, Q. J., Devinney, M. J., Chung, S., Terrando, N., Moretti, E. W., Browndyke, J. N., Mathew, J. P., and Berger, M., Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction., J Alzheimers Dis, vol. 80, no. 3, pp. 1281-1297, 2021.
J. Svensson, Blomqvist, M., Kettunen, P., Eckerström, C., Henricsson, M., Jonsson, M., Bjerke, M., Månsson, J. - E., and Wallin, A., Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia., J Alzheimers Dis, vol. 82, no. 2, pp. 781-790, 2021.
P. P. Chum, Hakim, M. A., and Behringer, E. J., Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model., J Alzheimers Dis, vol. 85, no. 1, pp. 91-113, 2021.
M. Chung, Rhee, H. Young, and Chung, W. Kuu, Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients., J Alzheimers Dis, vol. 80, no. 3, pp. 941-947, 2021.
A. A. Harb, Chen, R. J., Chase, H. S., Natarajan, K., and Noble, J. M., Clinical Features and Outcomes of Patients with Dementia Compared to an Aging Cohort Hospitalized During the Initial New York City COVID-19 Wave., J Alzheimers Dis, vol. 81, no. 2, pp. 679-690, 2021.
L. C. Beishon, Panerai, R. B., Budgeon, C., Subramaniam, H., Mukaetova-Ladinska, E., Robinson, T. G., and Haunton, V. J., The Cognition and Flow Study: A Feasibility Randomized Controlled Trial of the Effects of Cognitive Training on Cerebral Blood Flow., J Alzheimers Dis, vol. 80, no. 4, pp. 1567-1581, 2021.
S. G. Ryman, Yutsis, M., Tian, L., Henderson, V. W., Montine, T. J., Salmon, D. P., Galasko, D., and Poston, K. L., Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology., J Alzheimers Dis, vol. 80, no. 3, pp. 1243-1256, 2021.
F. Yu, Vock, D. M., Zhang, L., Salisbury, D., Nelson, N. W., Chow, L. S., Smith, G., Barclay, T. R., Dysken, M., and Wyman, J. F., Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial., J Alzheimers Dis, vol. 80, no. 1, pp. 233-244, 2021.

Pages